A recent report found that epithelial-mesenchymal transition (EMT) driven by TGF-β caused PD-L1 glycosylation by activating β-catenin to transcriptionally upregulate the expression of N-glycosyltransferase STT3, and eventually promoted immune escape in cancer stem cells (CSCs) (20). Here, TGFB1 is linked to cancer.